Status:
COMPLETED
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
University Hospital, Angers
University Hospital, Bordeaux
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Results about effects of symptomatic treatment on QoL appears conflicting in ALS patients. Moreover no clear effects of gastrotomy have be shown on survival. Prospective study on effect of tube feedin...
Detailed Description
Following data have been recorded each three months: QoL (MOS-SF 36 and ALSAQ), bodily mass index, testing and ALS-FRS scale, functional respiratory measures, impedance analysis, and the time for tube...
Eligibility Criteria
Inclusion
- patients \> 18 years-old
- ALS certain or probable
- vital capacity (respiratory) \> 70 %
- under riluzole
Exclusion
- ALS in family
- other conditions affected survival and QoL
- cognitive impairment
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
End Date :
June 1 2005
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT00337402
Start Date
January 1 2002
End Date
June 1 2005
Last Update
November 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clermont-Ferrand University Hospital
Clermont-Ferrand, France, 63003